Cargando…
Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis
We present the case of a 43-year-old woman with a diagnosis of pulmonary alveolar proteinosis, on chronic treatment with sargramostim, a recombinant granulocyte-macrophage colony-stimulating factor, who presented with the nephrotic syndrome secondary to biopsy-proven membranous nephropathy. We discu...
Autores principales: | Sewaralthahab, Kamal, Rennke, Helmut, Sewaralthahab, Sarah, Madias, Nicolaos E., Jaber, Bertrand L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437997/ https://www.ncbi.nlm.nih.gov/pubmed/29043131 http://dx.doi.org/10.5414/CNCS108420 |
Ejemplares similares
-
Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020) -
Pulmonary alveolar proteinosis: from classification to therapy
por: Salvaterra, Elena, et al.
Publicado: (2020) -
Congenital Pulmonary Alveolar Proteinosis
por: Hammami, Saber, et al.
Publicado: (2013) -
Pulmonary alveolar proteinosis in children
por: Bush, Andrew, et al.
Publicado: (2020) -
Rituximab rescue therapy for autoimmune pulmonary alveolar proteinosis
por: Bird, Daniel, et al.
Publicado: (2022)